Half-year report · Q2

Period2024-04-01 → 2024-09-30
Filed2024-11-12
StandardIFRS
ConsolidatedYes
Data checks12 of 12 passed
Key figures · 48
MetricValuePeriodScopeSource row
Revenue¥2.24T2024-04-01 → 2024-09-30Cons.Revenue IFRS
Revenue¥4.39T2023-04-01 → 2024-03-31Cons.Revenue IFRS (5-year summary)
Revenue¥2.15T2023-04-01 → 2023-09-30Cons.Revenue IFRS
Operating income¥136.7bn2024-04-01 → 2024-09-30Cons.Operating profit loss IFRS
Operating income¥138.6bn2023-04-01 → 2023-09-30Cons.Operating profit loss IFRS
Profit before tax¥106.1bn2024-04-01 → 2024-09-30Cons.Profit loss before tax IFRS
Profit before tax¥240.5bn2023-04-01 → 2024-03-31Cons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥130.2bn2023-04-01 → 2023-09-30Cons.Profit loss before tax IFRS
Net income (owners)¥40.9bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥119.6bn2023-04-01 → 2024-03-31Cons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥67.2bn2023-04-01 → 2023-09-30Cons.Profit loss attributable to owners of parent IFRS
Net income¥71.2bn2024-04-01 → 2024-09-30Cons.Profit loss IFRS
Net income¥178.4bn2023-04-01 → 2024-03-31Cons.Profit loss IFRS (5-year summary)
Net income¥94.1bn2023-04-01 → 2023-09-30Cons.Profit loss IFRS
Total assets¥5.95Tat 2024-09-30Cons.Assets IFRS
Total assets¥6.10Tat 2024-03-31Cons.Assets IFRS
Total assets¥6.12Tat 2023-09-30Cons.Total assets IFRS (5-year summary)
Total liabilities¥3.69Tat 2024-09-30Cons.Liabilities IFRS
Total liabilities¥3.83Tat 2024-03-31Cons.Liabilities IFRS
Net assets / equity¥2.26Tat 2024-09-30Cons.Equity IFRS
Net assets / equity¥2.28Tat 2024-03-31Cons.Equity IFRS
Net assets / equity¥2.21Tat 2023-09-30Cons.Equity IFRS
Net assets / equity¥1.99Tat 2023-03-31dCons.Equity IFRS
Equity (owners)¥1.74Tat 2024-09-30Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.76Tat 2024-03-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥1.72Tat 2023-09-30Cons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥297.5bnat 2024-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥294.9bnat 2024-03-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥398.8bnat 2023-09-30Cons.Cash and cash equivalents IFRS
Cash & equivalents¥297.2bnat 2023-03-31dCons.Cash and cash equivalents IFRS
Operating cash flow¥275.1bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥465.1bn2023-04-01 → 2024-03-31Cons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥195.7bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in operating activities IFRS
Investing cash flow−¥145.3bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥246.1bn2023-04-01 → 2024-03-31Cons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥115.6bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in investing activities IFRS
Financing cash flow−¥124.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities IFRS
Financing cash flow−¥241.7bn2023-04-01 → 2024-03-31Cons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥6.5bn2023-04-01 → 2023-09-30Cons.Net cash provided by used in financing activities IFRS
EPS (basic)¥28.762024-04-01 → 2024-09-30Cons.Basic earnings loss per share IFRS
EPS (basic)¥84.072023-04-01 → 2024-03-31Cons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥47.252023-04-01 → 2023-09-30Cons.Basic earnings loss per share IFRS
EPS (diluted)¥28.742024-04-01 → 2024-09-30Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥80.772023-04-01 → 2024-03-31Cons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥45.222023-04-01 → 2023-09-30Cons.Diluted earnings loss per share IFRS
Equity ratio29.2%at 2024-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.9%at 2024-03-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio28.2%at 2023-09-30Cons.Ratio of owners equity to gross assets IFRS (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 54
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥149.7bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥78.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥70.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥4.3bn
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥106.6bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥106.6bn
Reconciling Itemsreconcilingsegment profit2024-04-01 → 2024-09-30−¥5.1bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue2024-04-01 → 2024-09-30¥539.3bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue external2024-04-01 → 2024-09-30¥521.1bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥18.2bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentsegment profit2024-04-01 → 2024-09-30−¥10.5bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2024-04-01 → 2024-09-30¥643.0bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2024-04-01 → 2024-09-30¥639.4bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥3.6bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2024-04-01 → 2024-09-30¥91.9bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue2024-04-01 → 2024-09-30¥235.9bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue external2024-04-01 → 2024-09-30¥227.4bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥8.5bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentsegment profit2024-04-01 → 2024-09-30¥25.9bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue2024-04-01 → 2024-09-30¥232.6bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue external2024-04-01 → 2024-09-30¥232.5bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥50m
jpcrp040300-q2r_E00808-000Pharmareportable segmentsegment profit2024-04-01 → 2024-09-30¥41.4bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue2024-04-01 → 2024-09-30¥548.1bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue external2024-04-01 → 2024-09-30¥542.7bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥5.4bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentsegment profit2024-04-01 → 2024-09-30¥24.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2023-04-01 → 2023-09-30¥165.4bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2023-04-01 → 2023-09-30¥92.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2023-04-01 → 2023-09-30¥73.2bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2023-04-01 → 2023-09-30¥6.1bn
Reconciling Itemsreconcilingrevenue2023-04-01 → 2023-09-30−¥108.8bn
Reconciling Itemsreconcilingrevenue intersegment2023-04-01 → 2023-09-30−¥108.8bn
Reconciling Itemsreconcilingsegment profit2023-04-01 → 2023-09-30−¥5.5bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue2023-04-01 → 2023-09-30¥548.3bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue external2023-04-01 → 2023-09-30¥528.7bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥19.6bn
jpcrp040300-q2r_E00808-000Basic Materials And Polymersreportable segmentsegment profit2023-04-01 → 2023-09-30−¥14.6bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue2023-04-01 → 2023-09-30¥612.6bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue external2023-04-01 → 2023-09-30¥608.2bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥4.3bn
jpcrp040300-q2r_E00808-000Industrial Gasesreportable segmentsegment profit2023-04-01 → 2023-09-30¥80.3bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue2023-04-01 → 2023-09-30¥187.4bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue external2023-04-01 → 2023-09-30¥181.2bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥6.1bn
jpcrp040300-q2r_E00808-000MMA And Derivativesreportable segmentsegment profit2023-04-01 → 2023-09-30¥2.2bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue2023-04-01 → 2023-09-30¥219.4bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue external2023-04-01 → 2023-09-30¥219.3bn
jpcrp040300-q2r_E00808-000Pharmareportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥67m
jpcrp040300-q2r_E00808-000Pharmareportable segmentsegment profit2023-04-01 → 2023-09-30¥32.3bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue2023-04-01 → 2023-09-30¥525.7bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue external2023-04-01 → 2023-09-30¥520.2bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentrevenue intersegment2023-04-01 → 2023-09-30¥5.5bn
jpcrp040300-q2r_E00808-000Specialty Materialsreportable segmentsegment profit2023-04-01 → 2023-09-30¥18.8bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 887
ItemContextValueUnit
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row3Member0.0000
Number of shares held in own name treasury shares etcCurrentQuarterInstant_Row4Member84900
Number of shares held in others names treasury shares etcCurrentQuarterInstant_Row4Member-
Total number of shares held treasury shares etcCurrentQuarterInstant_Row4Member84900
Shareholding ratio treasury shares etcCurrentQuarterInstant_Row4Member0.0001
Number of shares held in own name treasury shares etcCurrentQuarterInstant81569600
Number of shares held in others names treasury shares etcCurrentQuarterInstant-
Total number of shares held treasury shares etcCurrentQuarterInstant81569600
Shareholding ratio treasury shares etcCurrentQuarterInstant0.0542
Revenue IFRSPrior1YTDDuration2149898000000JPY
Revenue IFRSCurrentYTDDuration2242066000000JPY
Cost of sales IFRSPrior1YTDDuration1587539000000JPY
Cost of sales IFRSCurrentYTDDuration1599376000000JPY
Gross profit IFRSPrior1YTDDuration562359000000JPY
Gross profit IFRSCurrentYTDDuration642690000000JPY
Selling general and administrative expenses IFRSPrior1YTDDuration448806000000JPY
Selling general and administrative expenses IFRSCurrentYTDDuration471976000000JPY
Other operating income IFRSPrior1YTDDuration37374000000JPY
Other operating income IFRSCurrentYTDDuration25875000000JPY
Other operating expenses IFRSPrior1YTDDuration16522000000JPY
Other operating expenses IFRSCurrentYTDDuration63014000000JPY
Share of profit loss of investments accounted for using equity method IFRSPrior1YTDDuration4213000000JPY
Share of profit loss of investments accounted for using equity method IFRSCurrentYTDDuration3085000000JPY
Operating profit loss IFRSPrior1YTDDuration138618000000JPY
Operating profit loss IFRSCurrentYTDDuration136660000000JPY
Finance income IFRSPrior1YTDDuration14737000000JPY
Finance income IFRSCurrentYTDDuration5237000000JPY
Finance costs IFRSPrior1YTDDuration23204000000JPY
Finance costs IFRSCurrentYTDDuration35795000000JPY
Profit loss before tax IFRSPrior1YTDDuration130151000000JPY
Profit loss before tax IFRSCurrentYTDDuration106102000000JPY
Income tax expense IFRSPrior1YTDDuration36009000000JPY
Income tax expense IFRSCurrentYTDDuration34944000000JPY
Profit loss IFRSPrior1YTDDuration94142000000JPY
Profit loss IFRSCurrentYTDDuration71158000000JPY
Profit loss attributable to owners of parent IFRSPrior1YTDDuration67212000000JPY
Profit loss attributable to owners of parent IFRSCurrentYTDDuration40921000000JPY
Profit loss attributable to non controlling interests IFRSPrior1YTDDuration26930000000JPY
Profit loss attributable to non controlling interests IFRSCurrentYTDDuration30237000000JPY
Basic earnings loss per share IFRSPrior1YTDDuration47.25
Basic earnings loss per share IFRSCurrentYTDDuration28.76
Diluted earnings loss per share IFRSPrior1YTDDuration45.22
Diluted earnings loss per share IFRSCurrentYTDDuration28.74
Profit loss IFRSPrior1YTDDuration94142000000JPY
Profit loss IFRSCurrentYTDDuration71158000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration7067000000JPY
Net change in fair value of equity instruments designated as measured at fair value through other comprehensive income net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-4397000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration2085000000JPY
Remeasurements of defined benefit plans net of tax items that will not be reclassified to profit or loss oci IFRSCurrentYTDDuration-776000000JPY
Share of other comprehensive income of investments accounted for using equity method net of tax items that will not be reclassified to profit or loss oci IFRSPrior1YTDDuration-11000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 12 of 12 passed
balance sheet identityconsolidated 2024-03-31pass
balance sheet identityconsolidated 2024-09-30pass
dei present pass
period resolution pass
statement vs summary · net income attributable to parentconsolidated 2023-04-01/2023-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2023-04-01/2023-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2023-04-01/2023-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · total assetsconsolidated 2024-03-31pass
statement vs summary · total assetsconsolidated 2024-09-30pass